ProVerum Medical is a medtech company that develops novel minimally invasive devices to treat benign prostatic hyperplasia.
ProVerum Medical is a medtech company that develops novel minimally invasive devices to treat benign prostatic hyperplasia. ProVerum's technology enables patients to receive safe and effective BPH treatment in the doctor's office or operating room in a less invasive, more patient-friendly manner than currently available BPH treatments.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 11, 2022 | Series A | €30M | 3 | Gilde Healthcare Lightstone Ventures | — | Detail |
May 8, 2018 | Seed | €3.50M | 6 | Atlantic Bridge University Fund | — | Detail |
Apr 26, 2017 | Seed | — | 1 | — | — | Detail |
May 25, 2016 | Seed | €3.49M | 6 | Atlantic Bridge University Fund | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Gilde Healthcare | Yes | Series A |
Lightstone Ventures | Yes | Series A |
Atlantic Bridge University Fund | — | Series A |
Boole | — | Seed |
Xenium Capital | — | Seed |
Enterprise Ireland | — | Seed |
Halo Business Angel Network | — | Seed |
Irrus Investments | — | Seed |
MedTech Strategist | — | Seed |